Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Teriparatide, Alendronate, Zoledronic Acid, and combination therapy in primary osteoporosis
IRCT201605169014N99Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of teriparatide, alendronate and zoledronic acid in osteoporosis (4 arms), sponsored by Hamadan University of Medical Sciences. Started Jun 2006; status: completed.
02
Drugs
teriparatidealendronatezoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on IRCT201605169014N99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201605169014N99.